Potential treatment options and future research to increase hepatitis C virus treatment response rate

Veronica Tencate1, Bruno Sainz, Scott J Cotler

  • 1Department of Medicine, Section of Hepatology, University of Illinois at Chicago, Chicago, IL, USA.

Insights

Hepatitis C virus (HCV) infection persists in most cases, leading to severe liver disease. New therapies targeting the viral life cycle offer improved treatment options for this global health concern.

Area of Science:

  • Hepatology
  • Virology
  • Immunology

Background:

  • Hepatitis C virus (HCV) affects over 170 million globally, causing significant liver disease.
  • Chronic HCV infection can lead to fibrosis, cirrhosis, steatosis, insulin resistance, and hepatocellular carcinoma.
  • Current standard care (pegylated interferon α + ribavirin) has limited efficacy and toxicity.

Purpose of the Study:

  • To review limitations of current HCV therapy.
  • To evaluate emerging HCV treatment strategies.
  • To discuss how understanding the HCV life cycle aids antiviral development.

Main Methods:

  • Literature review of current and emerging HCV therapies.
  • Analysis of research on HCV viral life cycle.
  • Evaluation of treatment outcomes for existing and novel antivirals.

Main Results:

  • Current standard care is effective in a subset of patients.
  • New HCV antivirals demonstrate improved efficacy and reduced toxicity.
  • Elucidating the HCV life cycle is crucial for developing targeted therapeutics.

Conclusions:

  • Development of effective, less toxic HCV antivirals is a priority.
  • Novel HCV therapeutics promise better treatment response rates.
  • Improved treatments are needed for both pre- and post-liver transplantation patients.

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...